# Great Lakes Pharmaceuticals, Inc. — Form D

Great Lakes Pharmaceuticals, Inc. of BROOMFIELD, CO, a company, filed a Form D exempt-offering notice with the SEC on 2014-09-11. The offering totals $24.0M, of which $11.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2014-09-11
- Form: D
- Accession: 0001619054-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $24.0M
- Amount sold: $11.2M
- Remaining: $12.8M
- Minimum investment: $1
- Investors: 28
- Date of first sale: 2014-08-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-224480

## Issuer

- Name: Great Lakes Pharmaceuticals, Inc.
- CIK: 0001619054
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 10901 WEST 120TH AVE. SUITE 105, BROOMFIELD, CO, 80021
- Phone: 303-681-7000

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Gino DiSciullo | Director | Lafayette, CO |
| Michael Fulton | Director | NOVI, MI |
| John Neis | Director | NOVI, MI |
| Fred Schwarzer | Director | Los Altos, CA |
| JEFF STEIN | Director | BALTIMORE, MD |
| Gino DiSciullo | Executive Officer | Lafayette, CO |

## More

- [CIK 1619054 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1619054&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001619054-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.